Yusuf (YP) Saleeby, MD - Update on COVID, Long COVID and LDN (LDN; low dose naltrexone)


‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever

Pain News Network
15 November 2022

Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions

Medical Dialogues
15 November 2022

Long COVID Is Common and Scary!

The People's Pharmacy
04 October 2022



The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details



This was an LDN Radio Show interview in 2022.

Linda Elsegood: Welcome to the LDN Radio Show, brought to you by the LDN Research Trust I'm your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.